Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2009 2
2013 2
2014 3
2015 7
2016 8
2017 7
2018 16
2019 10
2020 5
2021 11
2022 15
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F, Rizzato S, Bellu L, Pambuku A, Farina M, Magni G, Indraccolo S, Gardiman MP, Soffietti R, Zagonel V. Lombardi G, et al. Among authors: pasqualetti f. Lancet Oncol. 2019 Jan;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522967 Clinical Trial.
Stereotactic radiotherapy for bone oligometastases.
Colosimo C, Pasqualetti F, Aristei C, Borghesi S, Forte L, Mignogna M, Badii D, Bosio M, Paiar F, Nanni S, Bertocci S, Lastrucci L, Parisi S, Ingrosso G. Colosimo C, et al. Among authors: pasqualetti f. Rep Pract Oncol Radiother. 2022 Mar 22;27(1):40-45. doi: 10.5603/RPOR.a2022.0009. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 35402030 Free PMC article. Review.
The impact of survivorship bias in glioblastoma research.
Pasqualetti F, Barberis A, Zanotti S, Montemurro N, De Salvo GL, Soffietti R, Mazzanti CM, Ius T, Caffo M, Paiar F, Bocci G, Lombardi G, Harris AL, Buffa FM. Pasqualetti F, et al. Crit Rev Oncol Hematol. 2023 Aug;188:104065. doi: 10.1016/j.critrevonc.2023.104065. Epub 2023 Jun 29. Crit Rev Oncol Hematol. 2023. PMID: 37392899 Review.
Integrating stereotactic radiotherapy and systemic therapies.
Palumbo I, Pasqualetti F, Delishaj D, Gonnelli A, Aristei C, Borghesi S, Pirtoli L, Belgioia L, Arcangeli S. Palumbo I, et al. Among authors: pasqualetti f. Rep Pract Oncol Radiother. 2022 May 19;27(2):310-317. doi: 10.5603/RPOR.a2022.0020. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36299395 Free PMC article. Review.
Clinical Management of Diffuse Low-Grade Gliomas.
Lombardi G, Barresi V, Castellano A, Tabouret E, Pasqualetti F, Salvalaggio A, Cerretti G, Caccese M, Padovan M, Zagonel V, Ius T. Lombardi G, et al. Among authors: pasqualetti f. Cancers (Basel). 2020 Oct 16;12(10):3008. doi: 10.3390/cancers12103008. Cancers (Basel). 2020. PMID: 33081358 Free PMC article. Review.
Basic and Translational Advances in Glioblastoma.
Piccirillo SGM, Alonso MM, Pasqualetti F. Piccirillo SGM, et al. Among authors: pasqualetti f. Biomed Res Int. 2018 Mar 26;2018:1820345. doi: 10.1155/2018/1820345. eCollection 2018. Biomed Res Int. 2018. PMID: 29780818 Free PMC article. No abstract available.
New perspectives in liquid biopsy for glioma patients.
Pasqualetti F, Rizzo M, Franceschi S, Lessi F, Paiar F, Buffa FM. Pasqualetti F, et al. Curr Opin Oncol. 2022 Nov 1;34(6):705-712. doi: 10.1097/CCO.0000000000000902. Epub 2022 Sep 12. Curr Opin Oncol. 2022. PMID: 36093876 Review.
Stereotactic radiotherapy for oligometastases in the lymph nodes.
Pasqualetti F, Trippa F, Aristei C, Borghesi S, Colosimo C, Cantarella M, Mazzola R, Ingrosso G. Pasqualetti F, et al. Rep Pract Oncol Radiother. 2022 Mar 22;27(1):46-51. doi: 10.5603/RPOR.a2022.0007. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 35402021 Free PMC article. Review.
93 results